Study Looking at Moderate to Severe Plaque Psoriasis

What we are studying

The purpose of this study is to test an investigational oral medication and/or an approved drug given by subcutaneous injection (under the skin) and compare their effects to placebo (inactive substance which contains no medicine) in treating psoriasis . The study will test how your body tolerates one or both of these drugs and how well the investigational drug treats psoriasis.

Who we are studying

• Men and Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 18+

Eligibility Criteria

• Adult subjects older than 18 years of age with moderate to severe plaque psoriasis

What is involved

• There are a total of 27 office visits over a little more than 2 years
• Including screening visit

Compensation:

Qualified participants will be paid $50 for each completed visit (maximum $1,350).

Contact Information

Study Coordinator

Ann Boles, RN, CCRC

Email

dermadvertising@wakehealth.edu

Phone

336-716-3775